AI assistant
Beardsell Limited — Audit Report / Information 2025
Aug 5, 2025
61560_rns_2025-08-05_3d6c7797-9d31-4acf-86b0-ac8907cf5cc5.pdf
Audit Report / Information
Open in viewerOpens in your device viewer
==> picture [449 x 108] intentionally omitted <==
5[th] August 2025
To, National Stock Exchange of India Ltd. Exchange Plaza, 5[th] Floor Plot No.C/1, G Block Bandra Kurla Complex, Bandra (E) Mumbai – 400051 Scrip: BEARDSELL
Dear Madam / Sir,
Subject: Credit Rating by CARE
Pursuant to Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, this is to inform that M/s.CARE Ratings Limited (CARE) has upgraded the ratings for the bank facilities/FD Program of the Company as detailed below.
| Facilities/Instrument | Amount(Rs. Crore) | Rating | RatingAction |
|---|---|---|---|
| Long Term Bank Facilities |
29.20 (Reduced from 30.32) |
CARE BBB; Stable | Upgraded from CARE BBB-; Positive |
| Short Term Bank Facilities |
30.00 | CARE A3+ | Upgraded from CARE A3 |
| Fixed Deposit | 5.00 | CARE BBB; Stable | Upgraded from CARE BBB-;Positive |
The Rating letter provided by CARE is attached herewith and available on the website of the Company at www.beardsell.co.in
We request you to kindly take the above on record.
Thanking you,
Yours faithfully, For BEARDSELL LIMITED
KANHU Digitally signed by KANHU CHARAN CHARAN SAHU Date: 2025.08.05 SAHU 10:35:51 +05'30'
Company Secretary & Compliance Officer
==> picture [83 x 15] intentionally omitted <==
==> picture [419 x 55] intentionally omitted <==
Press Release
Beardsell Limited
| Facilities/Instruments | Amount (₹ crore) | Rating1 | Rating Action |
|---|---|---|---|
| Long-term bank facilities | 29.20 (Reduced from 30.32) |
CARE BBB; Stable | Upgraded from CARE BBB-; Positive |
| Short-term bank facilities | 30.00 | CARE A3+ | Upgraded from CARE A3 |
| Fixed deposit | 5.00 | CARE BBB; Stable | Upgraded from CARE BBB-; Positive |
Details of instruments/facilities in Annexure-1.
Rationale and key rating drivers
Revision in ratings assigned to bank facilities of Beardsell Limited (BSL) factors in sustained growth in scale of operation, while sustaining operating margin and improvement in capital structure in the last three years. Ratings continue to derive strength from the experience of promoters and the company’s long track record in thermal insulation products and engineering industry and long-standing relationships with clients facilitating renewal of contracts. However, ratings are constrained by relatively moderate profitability margins, susceptibility to volatile raw material prices, and highly competitive and cyclical industry.
Rating sensitivities: Factors likely to lead to rating actions
Positive factors
-
Improvement in scale of operations ranging above ₹350 crore with profit before interest, lease rentals, depreciation, and taxation (PBILDT) margin in the range of 9-10% on a sustained basis.
-
Improvement in total debt to gross cash accruals (TD/GCA) below 1.50x.
Negative factors
-
Declining PBILDT margin below 5% on a sustained basis.
-
Elongating receivables, stretching the liquidity position.
Analytical approach: Consolidated
CARE Ratings Limited (CareEdge Ratings) has analysed BSL’s credit profile by consideringthe consolidated financial statements (comprising BSL and its wholly owned subsidiary, Sarovar Insulation Private Limited and Controlled entity: Saideep Polythermal) owing to financial and operational linkages between the parent and its subsidiary. Companies are engaged in similar/same line of business and are run by a common management. Details of subsidiaries are listed under Annexure 6.
Outlook: Stable
CareEdge Ratings believes that BSL shall sustain its performance in the medium term and maintain a comfortable financial credit risk profile.
Detailed description of key rating drivers:
Key strengths
Sustained growth in scale of operations and stable operating margins
BSL has demonstrated steady upward trajectory in its scale of operation, growing from ₹132 crore in FY21 to ₹268 crore in FY25, recording a compound annual growth rate (CAGR) of 13%. Despite drop in realisation, followed by easing raw material cost, the company achieved 9% growth in total operating income (TOI) in FY25. Growth was supported by improved order flow especially from public sector undertakings (PSU) customers with higher proportion of orders covering installation and annual maintenance. The company’s expanded polystyrene (EPS) segment witnessed an upward trend, with sales growing by 14% to ₹110.21 crore in FY25 (PY: ₹96.04 crore), while Prefab Panels and work contract income together grew by 7% in FY25 ₹139.87 crore (PY ₹130.23 crore). Despite pricing pressures from intensified competition, especially from unorganised players, the company maintained a stable PBILDT margin at 8.64% in FY25 (PY: 8.86%). Resilience in profitability was supported by a higher contribution from
1Complete definition of ratings assigned are available at www.careratings.com and other CARE Ratings Limited’s publications.
CARE Ratings Ltd.
1
Press Release
installation and annual maintenance contract (AMC) services, which offer better margins compared to the standalone product supply.
Improved capital structure and debt coverage indicators
The company’s capital structure improved aided by reduced debt level and improved accretion. The company’s overall gearing improved to 0.47x (PY: 0.65x) and total outside liabilities to total net worth (TOL/TNW) improved to 1.19x (PY: 1.31x) as on March 31, 2025. Debt coverage indicators also improved marked by interest coverage ratio of 6.02x (PY: 3.97x) and TD/GCA of 2.12x (PY: 2.82x) in FY25. In FY25, the company planned to relocate the Thane plant and enhance EPS capacity through a capex of ₹10–15 crore including a proposed term loan of ₹5 crore, the plan was deferred due to lower-than-expected EPS demand. The project is expected to be launched on H2FY26. With anticipated improvement in accruals, the company is expected to maintain its comfortable capital structure going forward.
Extensive experience of promoters and management
Incorporated in 1936, BSL holds a legacy of eight decades in the trading and manufacturing industry. BSL’s day-to-day operations are currently managed by Amrith Anumolu, Executive Director, and part of the promoter family. He has two decades of experience in the engineering industry. Anumolu is assisted by a team of well-qualified professionals heading functional departments.
Long track record of operations in manufacturing of thermal insulations products
BSL started operations as a trading company in 1936 and in 1967, diversified into the production of a thermal insulation product, EPS. The EPS division manufactures custom designed packaging materials catering to consumer durables (refrigerators, microwave ovens, and washing machines among others), entertainment electronics, pharmaceuticals, and food products. This division accounted for 41% of the TOI in FY25. The company offers two engineering products in the Prefab segment – Isobuild and Quikbuild panels. Isobuild division manufactures panels that are used for cold storage, blast freezers, and clean rooms. Quikbuild division is a modular construction system that uses prefabricated panels, which are erected on a plinth and plastered with sand or cement to form walls to create buildings. The company also undertakes installation and maintenance under work contracts for PSUs in the prefab panels division. The prefab segment (Isobuild & Quikbuild) accounts for 52% of TOI in FY25. The company is also engaged in trading electric motors being the channel partner of Siemens Motors in Tamil Nadu. Trading division accounts for 6% of TOI in FY25.
Key weaknesses
Volatility in profitability margins susceptible to change in raw material prices
The company's margins are significantly influenced by petroleum-based raw materials price volatility, such as EPS resins and other chemicals, which are essential for production. The company faces challenges in passing on increased raw material costs to customers due to stiff competition in the industry. With the increased focus on works contracts by undertaking installation and maintenance, and the product supply expected to support the business’ profitability margins.
Stiff competition due to fragmented industry structure
BSL has two major business segments – thermocol packaging and prefabricated panel products – which form a major part of the revenue. The end-user industry primarily includes consumer durables, pharma companies, engineering, and construction sector. This keeps BSL’s operations cyclical, depending on the demand from end-user industries. As entry and exit barriers in this industry are low, the industry has several organised and unorganised players, which puts pressure on margins.
Liquidity : Adequate
The company’s working capital cycle remained nearly stable in the last four years at ~30 days. Average working capital utilisation was ~72% for 11 months ended May 31, 2025. The company has GCA of ₹17.51 crore in FY25 and cash and bank balance of ₹5.73 crore as on March 31, 2025, against the estimated debt repayment and deposit maturity of ₹5.40 crore in FY26.
Applicable criteria
Consolidation Definition of Default Liquidity Analysis of Non-financial sector entities Rating Outlook and Rating Watch Manufacturing Companies Financial Ratios – Non financial Sector Short Term Instruments
CARE Ratings Ltd.
2
Press Release
About the company and industry
Industry classification
| Macroeconomic indicator | Sector | Industry | Basic industry |
|---|---|---|---|
| Diversified | Diversified | Diversified | Diversified |
BSL was incorporated in 1936 as a trading company, which eventually diversified into manufacturing a variety of industrial products serving different customer segments. The company has three divisions, EPS products, Isobuild, and Quikbuild. The company is also engaged in trading electric motors from Siemens. BSL has eight manufacturing units in Chennai, Thane, Bengaluru, Karad, Hyderabad, Hapur, Kochi, and Coimbatore (including the subsidiary and controlled entity). The company has an installed capacity of producing 3,720 metric tonnes (MT) of EPS, 5,76,000 sq.mt of Isobuild and 2,89,000 sq.mt of Quikbuild as on March 31, 2025.
Consolidated
| Brief Financials (₹ crore) | March 31, 2023 (A) | March 31, 2024 (A) | March 31, 2025 (A) |
|---|---|---|---|
| Total operating income | 232.01 | 245.10 | 268.51 |
| PBILDT | 18.19 | 21.72 | 23.21 |
| PAT | 8.50 | 8.23 | 9.83 |
| Overall gearing (times) | 0.90 | 0.65 | 0.47 |
| Interest coverage (times) | 4.18 | 3.97 | 6.02 |
A: Audited; Note: these are latest available financial results
Status of non-cooperation with previous CRA:
BSL has not co-operated with ICRA Limited (ICRA), where it has classified the issuer as ‘non-cooperative’ vide its press release dated July 16, 2025. The reason provided by ICRA Ratings was non-furnishing of sufficient information towards monitoring ratings.
BSL has not co-operated with CRISIL Ratings Limited (CRISIL), where it has classified the issuer as ‘non-cooperative’ vide its press release dated December 27, 2024. The reason provided by CRISIL Ratings was non-furnishing of sufficient information towards monitoring ratings.
Any other information: Not applicable
Rating history for last three years: Annexure-2
Detailed explanation of covenants of rated instrument / facility: Annexure-3
Complexity level of instruments rated : Annexure-4
Lender details : Annexure-5
Annexure-1: Details of instruments/facilities
| Name of the Instrument |
ISIN | Date of Issuance (DD-MM- YYYY) |
Coupon Rate (%) |
Maturity Date (DD- MM-YYYY) |
Size of the Issue (₹ crore) |
Rating Assigned and Rating Outlook |
|---|---|---|---|---|---|---|
| Fixed Deposit | - | - | Up to three years |
5.00 | CARE BBB; Stable |
|
| Fund-based - LT-Cash Credit |
- | - | - | 20.00 | CARE BBB; Stable |
|
| Fund-based - LT-Term Loan |
- | - | 30-10-2030 | 9.20 | CARE BBB; Stable |
CARE Ratings Ltd.
3
Press Release
| Non-fund- based - ST- BG/LC |
- | - | - | 30.00 | CARE A3+ | |
|---|---|---|---|---|---|---|
Annexure-2: Rating history for last three years
| Sr. No. | Name of the | Current Ratings | Current Ratings | Current Ratings | ||||
|---|---|---|---|---|---|---|---|---|
| Rating History | ||||||||
| D | D | D | Date(s) and Rating(s) assigned in 2022-2023 |
|||||
| ate(s) d |
ate(s) d |
ate(s) d |
||||||
| Instrument/Bank | Amount | an Rti |
an Rti |
an Rti |
||||
| Facilities | Type | Outstanding | Rating | ang(s) assined |
ang(s) assined |
ang(s) assined |
||
| (₹ crore) | g in 2025- 2026 |
g in 2024- 2025 |
g in 2023- 2024 |
|||||
| 1 | Fund-based - LT- Cash Credit |
LT | - | - | - | - | - | 1)CARE BB+; Stable (26-Dec-22) 2)Withdrawn (26-Dec-22) 3)CARE BB+; Stable (13-Oct-22) |
| 2 | Fund-based - LT- Term Loan |
LT | - | - | - | - | - | 1)Withdrawn (26-Dec-22) 2)CARE BB+; Stable (26-Dec-22) 3)CARE BB+; Stable (13-Oct-22) |
| 3 | Non-fund-based - ST-BG/LC |
ST | - | - | - | - | - | 1)CARE A4+ (26-Dec-22) 2)Withdrawn (26-Dec-22) 3)CARE A4+ (13-Oct-22) |
| 4 | Fund-based - LT- Cash Credit |
LT | 20.00 | CARE BBB; Stable |
- | 1)CARE BBB-; Positive (09-Aug- 24) |
1)CARE BBB-; Stable (31-Oct- 23) |
- |
| 5 | Non-fund-based - ST-BG/LC |
ST | 30.00 | CARE A3+ |
- | 1)CARE A3 (09-Aug- 24) |
1)CARE A3 (31-Oct- 23) |
- |
| 6 | Fund-based - LT- Term Loan |
LT | 9.20 | CARE BBB; Stable |
- | 1)CARE BBB-; Positive (09-Aug- 24) |
1)CARE BBB-; Stable (31-Oct- 23) |
- |
CARE Ratings Ltd.
4
Press Release
| 7 | Fixed Deposit | LT | 5.00 | CARE BBB; Stable |
- | 1)CARE BBB-; Positive (09-Aug- 24) |
- | - |
|---|---|---|---|---|---|---|---|---|
LT: Long term; ST: Short term.
Annexure-3: Detailed explanation of covenants of rated instruments/facilities: Not applicable
Annexure-4: Complexity level of instruments rated
| Sr. No. | Name of the Instrument | Complexity Level |
|---|---|---|
| 1 | Fixed Deposit | Simple |
| 2 | Fund-based - LT-Cash Credit | Simple |
| 3 | Fund-based - LT-Term Loan | Simple |
| 4 | Non-fund-based - ST-BG/LC | Simple |
Annexure-5: Lender details
To view lender-wise details of bank facilities please click here
Annexure-6: List of entities consolidated
| Sr No | Name of the entity | Extent of consolidation | Rationale for consolidation |
|---|---|---|---|
| 1 | Sarovar Insulation Private Limited | Full | Similar line of business or requires support |
| 2 | Saideep Polytherm |
Note on complexity levels of rated instruments: CareEdge Ratings has classified instruments rated by it based on complexity. Investors/market intermediaries/regulators or others are welcome to write to [email protected] for clarifications.
CARE Ratings Ltd.
5
Press Release
Contact us
| Media Contact Mradul Mishra Director CARE Ratings Limited Phone: +91-22-6754 3596 E-mail: [email protected] Relationship Contact Ankur Sachdeva Senior Director CARE Ratings Limited Phone: +91-22-6754 3444 E-mail: [email protected] |
Analytical Contacts Sandeep P Director CARE Ratings Limited Phone: 044 2850 1002 E-mail: [email protected] Ratheesh Kumar Associate Director CARE Ratings Limited Phone: 044 2850 1020 E-mail: [email protected] Bhuvaneshwaran Balamurugan Analyst CARE Ratings Limited E-mail: [email protected] |
|
|---|---|---|
About us:
Established in 1993, CareEdge Ratings is one of the leading credit rating agencies in India. Registered under the Securities and Exchange Board of India, it has been acknowledged as an External Credit Assessment Institution by the Reserve Bank of India. With an equitable position in the Indian capital market, CareEdge Ratings provides a wide array of credit rating services that help corporates raise capital and enable investors to make informed decisions. With an established track record of rating companies over almost three decades, CareEdge Ratings follows a robust and transparent rating process that leverages its domain and analytical expertise, backed by the methodologies congruent with the international best practices. CareEdge Ratings has played a pivotal role in developing bank debt and capital market instruments, including commercial papers, corporate bonds and debentures, and structured credit. For more information: www.careratings.com
Disclaimer:
This disclaimer pertains to the ratings issued and content published by CARE Ratings Limited (“CareEdge Ratings”). Ratings are opinions on the likelihood of timely payment of the obligations under the rated instrument and are not recommendations to sanction, renew, disburse, or recall the concerned bank facilities or to buy, sell, or hold any security. Any opinions expressed herein are in good faith and are subject to change without notice. The rating reflects the opinions as on the date of the rating. A rating does not convey suitability or price for the investor. The rating agency does not conduct an audit on the rated entity or an independent verification of any information it receives and/or relies on for the rating exercise. CareEdge Ratings has based its ratings/outlook on the information obtained from reliable and credible sources. CareEdge Ratings does not, however, guarantee the accuracy, adequacy, or completeness of any information and is not responsible for any errors or omissions and the results obtained from the use of such information. The users of the rating should rely on their own judgment and may take professional advice while using the rating in any way. CareEdge Ratings shall not be liable for any losses that user may incur or any financial liability whatsoever to the user of the rating. The use or access of the rating does not create a client relationship between CareEdge Ratings and the user.
CAREEDGE RATINGS DISCLAIMS WARRANTY OF ANY KIND, EXPRESS, IMPLIED OR OTHER WARRANTIES OR CONDITIONS, TO THE EXTENT PERMITTED BY APPLICABLE LAWS, INCLUDING WARRANTIES OF MERCHANTABILITY, ACCURACY, COMPLETENESS, ERROR-FREE, NON-INFRINGEMENT, NON-INTERRUPTION, SATISFACTORY QUALITY, FITNESS FOR A PARTICULAR PURPOSE OR INTENDED USAGE.
Most entities whose bank facilities/instruments are rated by CareEdge Ratings have paid a credit rating fee, based on the amount and type of bank facilities/instruments. CareEdge Ratings or its subsidiaries/associates may also be involved with other commercial transactions with the entity. CareEdge Ratings does not act as a fiduciary by providing the rating. The ratings are intended for use only within the jurisdiction of India. The ratings of CareEdge Ratings do not factor in any rating-related trigger clauses as per the terms of the facilities/instruments, which may involve acceleration of payments in case of rating downgrades. However, if any such clauses are introduced and triggered, the ratings may see volatility and sharp downgrades. CareEdge Ratings has established policies and procedures as required under applicable laws and regulations which are available on its website.
Privacy Policy applies. For Privacy Policy please refer to https://www.careratings.com/privacy_policy
© 2025, CARE Ratings Limited. All Rights Reserved.
This content is being published for the purpose of dissemination of information. Any use or reference to the contents herein on an “as-is” basis is permitted with due acknowledgement to CARE Ratings. Reproduction or retransmission in whole or in part is prohibited except with prior written consent from CARE Ratings.
For detailed Rating Report and subscription information, please visit www.careratings.com
CARE Ratings Ltd.
6